Cqs (Us), LLC Grifols Sa Transaction History

Cqs (Us), LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$7.71 - $11.56 $2 Million - $3.01 Million	-260,000 Reduced 95.86%	11,230 $129,000
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $2.88 Million - $3.6 Million	-271,230 Reduced 50.0%	271,230 $3.18 Million
Q2 2022 Aug 12, 2022	BUY	$10.6 - $13.28 $2.88 Million - $3.6 Million	271,230 Added 100.0%	542,460 $6.37 Million
Q4 2020 Feb 03, 2021	BUY	$16.86 - $19.67 $4.57 Million - $5.34 Million	271,230 New	271,230 $4.99 Million
Q3 2020 Nov 12, 2020	SELL	$15.4 - $20.16 $4.48 Million - $5.86 Million	-290,918 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$16.28 - $25.63 $4.74 Million - $7.46 Million	290,918 New	290,918 $5.81 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Cqs (Us), LLC, based on Form 13F filings with the SEC.

Stay updated on Cqs (Us), LLC with notifications on news.